Zenotech Laboratories Limited

About

Zenotech Laboratories Limited manufactures and markets pharmaceutical specialty generic injectables in the oncology and anesthesiology markets in India. It offers contract manufacturing services for parenteral depot formulations, ophthalmic, oncology oral and injectables, and general injectables. The company also leases out its biotech facility and equipment. In addition, it provides granulocyte-colony stimulating factor and granulocyte-macrophage colony-stimulating factor products. Zenotech Laboratories Limited was incorporated in 1989 and is based in Hyderabad, India.

Quarterly Results

Rs. Crores · hover row for definition

Metric	Sep 2006	Jun 2006
Sales	5.27	2.83
Expenses	3.98	4.30
Operating Profit	1.29	-1.47
OPM %	24.48	-51.94
Other Income	0.23	0.10
Depreciation	0.34	0.12
Interest	0.45	0.30
Profit before tax	0.73	-1.79
Tax %	0.00	0.00
Net Profit	0.73	-1.79
EPS in Rs	0.14	—

Profit & Loss

Annual · Rs. Crores

Metric	Mar 2010	Mar 2009	Mar 2008	Mar 2007	Mar 2006
Sales	7.00	6.00	8.00	13.00	12.00
Expenses	16.00	24.00	18.00	19.00	15.00
Operating Profit	-9.00	-18.00	-10.00	-6.00	-3.00
OPM %	-143.00	-292.00	-121.00	-49.00	-20.00
Other Income	2.00	5.00	2.00	9.00	0.00
Interest	2.00	1.00	3.00	2.00	1.00
Depreciation	3.00	3.00	3.00	2.00	0.00
Profit before tax	-13.00	-18.00	-14.00	-1.00	-3.00
Tax %	0.00	0.00	17.00	-250.00	6.00
Net Profit	-13.00	-18.00	-16.00	2.00	-4.00
EPS in Rs	-2.05	-2.88	-2.64	0.32	—
Dividend Payout %	0.00	0.00	0.00	0.00	0.00

Balance Sheet

Annual · Rs. Crores — latest first

Metric	Mar 2010	Mar 2009	Mar 2008	Mar 2007	Mar 2006
Equity Capital	34.00	34.00	34.00	29.00	16.00
Reserves	62.00	74.00	92.00	25.00	6.00
Borrowings	10.00	17.00	19.00	36.00	31.00
Other Liabilities	4.00	5.00	8.00	10.00	21.00
Total Liabilities	111.00	131.00	153.00	100.00	74.00
Fixed Assets	71.00	62.00	61.00	60.00	16.00
CWIP	13.00	24.00	15.00	9.00	40.00
Investments	0.00	0.00	0.00	0.00	0.00
Other Assets	27.00	45.00	77.00	30.00	19.00
Total Assets	111.00	131.00	153.00	100.00	74.00

Cash Flows

Annual · Rs. Crores — latest first

Metric	Mar 2010	Mar 2009	Mar 2008	Mar 2007	Mar 2006
Cash from Operating Activity	-10.00	-16.00	-3.00	-7.00	-16.00
Cash from Investing Activity	29.00	20.00	-67.00	-15.00	-56.00
Cash from Financing Activity	-8.00	-4.00	70.00	22.00	74.00
Net Cash Flow	11.00	1.00	0.00	0.00	2.00
Free Cash Flow	-11.00	-28.00	-13.00	-22.00	-70.00
CFO/OP %	102.00	82.00	23.00	109.00	619.00

Ratios

Annual · Days / % — latest first

Metric	Mar 2010	Mar 2009	Mar 2008	Mar 2007	Mar 2006
Debtor Days	96.00	36.00	85.00	273.00	145.00
Inventory Days	279.00	172.00	575.00	331.00	139.00
Days Payable	253.00	226.00	421.00	455.00	451.00
Cash Conversion Cycle	123.00	-18.00	240.00	149.00	-167.00
Working Capital Days	286.00	250.00	196.00	279.00	55.00
ROCE %	-9.00	-12.00	-9.00	2.00	—

Shareholding Pattern

% holding — latest first

Holder	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Promoters	68.84	68.84	68.84	68.84	68.84	68.84	68.84	68.84	68.84	68.84	68.84	68.84
DIIs	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Public	30.17	30.17	30.18	30.18	30.17	30.18	30.18	30.18	30.16	30.17	30.17	30.17
No. of Shareholders	10,161	10,301	10,464	10,670	10,661	10,690	10,667	10,641	9,750	9,819	9,762	9,589